Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar;132(3):313-320.
doi: 10.1016/j.anai.2023.09.004. Epub 2023 Sep 22.

Shared decision-making in food allergy: Navigating an exciting era

Affiliations
Review

Shared decision-making in food allergy: Navigating an exciting era

Aikaterini Anagnostou. Ann Allergy Asthma Immunol. 2024 Mar.

Abstract

Objective: Shared decision-making (SDM) is increasingly used in food allergy. We review its use in the areas of prevention, diagnosis, and management.

Data sources: PubMed and online SDM resources.

Study selections: Studies and reviews relevant to SDM and areas in food allergy that decision-making may be applied were selected for discussion.

Results: Food allergy represents an area with multiple opportunities for SDM. Patients, on one hand, need to obtain the necessary information and understanding of existing options from the allergist. The allergist, on the other hand, needs to understand "where the patient is coming from," their needs, preferences, and values, so that jointly they can reach a decision that is responsive to these. Benefits of SDM include a better understanding of disease by patients, improved compliance with medication, better health outcomes, decreased health care costs, and improved ability of patients to manage their disease and make informed choices.

Conclusion: In food allergy prevention, diagnosis, and management, multiple preference-sensitive options exist for patients where SDM may be used during allergy consultations, alongside decision aids. Decision aids are tools that assist and support patients during the SDM process, by supplementing the patient-physician interaction.

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr Anagnostou reports receiving institutional funding from Aimmune; serving as an advisory board member to DBV Technologies and Novartis; and receiving consultation/speaker fees from ALK-Abelló, Adelphi, and Aimmune Therapeutics.

Similar articles

Cited by

LinkOut - more resources